1. Independent Auditors Review Reports on the quarterly and half yearly Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2025 duly signed by Auditors;2. Unaudited Standalone Financial Results for the quarter and half year ended 30th September 2025 in your prescribed proforma duly signed by the Managing Director;3. Independent Auditors Review Reports on the quarterly and half yearly Unaudited Consolidated Financial Results for the quarter and half year ended 30th September 2025 duly signed by Auditors;4. Unaudited Consolidated Financial Results for the quarter and half year ended 30th September 2025 in your prescribed proforma duly signed by the Managing Director;5. Outcome/Proceedings of the Board Meeting dated 14th November 2025.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]